Christian Rommel has been Roche pRED’s Global Head of Oncology Discovery since 2014. He joined
Roche from Amgen, where he was most recently Vice President of External Research and
Development. Before that role, Christian was Amgen’s Vice President, Research Oncology.
Previously, Christian served as Chief Scientific Officer of Intellikine, a private biotech company based
in San Diego, from its inception to acquisition by Takeda in December 2011. He was responsible for
all discovery and non-clinical activities and led parts of the early clinical development functions.
From 2000 to 2007, Christian was Head of Target Research at Merck-Serono in Geneva, Switzerland.
He also worked as a scientist in the team of George Yancopoulos at Regeneron Pharmaceuticals,
Christian supported the transition of multiple small or large molecule projects from discovery into
clinical development. He was also involved in several asset in-/out-licensing projects as well as M&A
transactions and/or integration.